|
2025
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central ner... |
|
|
G/S
|
Providing medical information |
|
|
Invention
|
Anti-cancer combination therapies comprising ctla-4 and pd-1 blocking agents.
Anti-cancer combin... |
|
|
G/S
|
Pharmaceutical preparations for prevention or treatment of infectious diseases Providing medical ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of infectious diseases Providing med... |
|
|
Invention
|
Engineered phenylalanine ammonia lyase polypeptides and methods of making and using the same. The... |
|
|
Invention
|
Process for preparing amino phenyl compounds. The instant invention is directed to an efficient a... |
|
|
Invention
|
Granzyme b pet imaging agents. The invention is directed to compounds of Formula (I) and their ph... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, canc... |
|
|
Invention
|
Use of conjugate in treating tumor disease and method. 12m13m24m3γγ-A Formula (I) |
|
|
Invention
|
Use of an immunoconjugate for the treatment of gastric cancer. The present disclosure relates to ... |
|
|
Invention
|
Crystals of anti-human tau monoclonal antibody. Crystals of an antibody that specifically binds t... |
|
|
Invention
|
Pyridinone derivatives as selective cytotoxic agents against hiv infected cells.
The present dis... |
|
|
Invention
|
Polypeptides for bioconjugation. Disclosed are polypeptides that can be used for bioconjugation. ... |
|
|
Invention
|
System for medicinal supply monitoring and management with controlled packaging of medicinal prod... |
|
|
Invention
|
System for medicinal supply monitoring and management with digital display labeling.
A medicinal... |
|
|
Invention
|
System for medicinal supply monitoring and management for pooled medicinal product across studies... |
|
|
Invention
|
System for medicinal supply monitoring and management. A medicinal supply management system manag... |
|
|
Invention
|
N-oxide derivatives as selective cytotoxic agents. The present disclosure is directed to N-oxide ... |
|
|
Invention
|
Modulation of cell growth and viability using nucleoside transport inhibitors, inhibitors of aden... |
|
|
Invention
|
3-sulfamoyl benzoate ester and benzamide compounds as tead modulators. Provided are compounds of ... |
|
|
Invention
|
Combination therapies for the treatment of hr+/her2- metastatic or locally advanced breast cancer... |
|
|
Invention
|
Methods and compositions for treatment of cancer with anti-cd27 antibodies. The present disclosur... |
|
|
Invention
|
N-biaryl sulfonamides as modulators of the hippo pathway. Provided are compounds of Formula I: an... |
|
|
Invention
|
Evaluating neural network prediction confidence using generative reconstruction of test image.
A... |
|
|
Invention
|
Methods of using cyclic peptides that bind to tnfr1. Provided herein, in certain aspects, are met... |
|
|
G/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals |
|
|
Invention
|
Methods of separating host cell lipases from a production protein in chromatographic processes.
... |
|
|
Invention
|
Viral fusion inhibitors. The present invention relates to viral fusion inhibitors, as well as use... |
|
2024
|
Invention
|
Process for preparing beta 3 agonists and intermediates.
The application is directed to efficien... |
|
|
G/S
|
pharmaceutical preparations for veterinary use, namely, anti-inflammatories, insecticides, and ho... |
|
|
Invention
|
Agonists of trem2 activity. The present disclosure is directed to compounds of Formula (I) and th... |
|
|
Invention
|
Agonists of trem2 activity. The present disclosure is directed to compounds of Formula I and thei... |
|
|
Invention
|
Pcsk9 antagonist compounds.
Disclosed are compounds of Formula I, or a salt thereof:
Disclosed... |
|
|
Invention
|
Substituted isoquinoline derivatives and methods of use thereof. Provided are novel Substituted I... |
|
|
Invention
|
Process for preparing n-aminoalkylated tryptophan compounds. The present invention relates to pro... |
|
|
Invention
|
Azaindazole derivatives useful as inhibitors of nod-like receptor protein 3.
Novel compounds of ... |
|
|
G/S
|
Pharmaceutical preparations for use in Oncology |
|
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central ner... |
|
|
G/S
|
pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
G/S
|
pharmaceutical preparations, namely, anti-infectives and antivirals; human vaccine preparations p... |
|
|
G/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
G/S
|
Pharmaceuticals and vaccines for human and veterinary use;
medicinal, pharmaceutical, therapeuti... |
|
|
Invention
|
26-valent pneumococcal conjugate vaccines and methods of use thereof. S. pneumoniae S. pneumoniae... |
|
|
Invention
|
Pneumococcal conjugate vaccines and methods of use thereof.
The invention is related to 26-valen... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of respiratory, gynecological, and neurological dis... |
|
|
Invention
|
Interactive gowning and gowning verification.
A device includes a camera, a display and a comput... |
|
2023
|
Invention
|
Engineered enzyme for preparing a hydroxylated indanone intermediate useful in the synthesis of b... |
|
|
Invention
|
Immunogenic compositions for herpes simplex virus proteins.
The disclosure provides live attenua... |
|
|
Invention
|
Disruption of kdm4a in t cells to enhance immunotherapy.
The application provides modified immun... |
|
|
Invention
|
Methods for treating cancer, or von-hippel lindau disease using a combination of a tigit antagoni... |
|
|
Invention
|
Ripk1 inhibitors and methods of use.
Described herein are compounds of Formula 1 or a pharmaceut... |
|
|
Invention
|
Inhibitors of msba as antibiotics, pharmaceutical compositions, and uses thereof.
The present di... |
|
|
Invention
|
Macrocycles as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof.
The present inve... |
|
|
Invention
|
Anti-integrin antibodies and uses thereof.
The integrin family of cell adhesion molecules has em... |
|
|
Invention
|
Orexin receptor agonists.
The present invention is directed to compounds of Formula I which are ... |
|
|
Invention
|
Stable formulations of anti-ilt4 antibodies or antigen-binding fragments thererof in combination ... |
|
|
Invention
|
Process for preparing agglomerated crystalline medium-chain fatty acid sodium salts.
The process... |
|
|
Invention
|
Process for preparing ((1s,2s)-2-(5-methylpyridin-2-yl)cyclopropyl)-methanol.
The present invent... |
|
|
Invention
|
Controlled release vaccine formulations.
The present disclosure provides, among other things, a ... |
|
|
Invention
|
Protease inhibitors for treating or preventing coronavirus infection.
The present invention prov... |
|
2022
|
Invention
|
Multi-cartridge injector and methods of making and using same.
A multi-cartridge injector includ... |
|
|
Invention
|
Pnpla3-targeting short interfering rna (sirna) molecules and uses thereof.
Disclosed herein are ... |
